Researcher.Life Logo

BioFactors : Impact Factor & More

eISSN: 1872-8081pISSN: 0951-6433

Key Metrics

CiteScore
10
H-Index
106
Impact Factor
5 - 10
SJR
Q1Biochemistry
SNIP
1.29
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on BioFactors

BioFactors Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1988
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in BioFactors ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in BioFactors

ISG15 Mediates Oxidative Stress Modulation in T2DM Patients by Directly Targeting PIK3R2.
  • 1 Mar 2026
  • BioFactors (Oxford, England)
Title not available
  • 1 Mar 2026
  • BioFactors
Phytoestrogenic Isoflavone Formononetin Attenuates Motor Deficits and Mitochondrial Impairment by Regulating SIRT1/PGC-1α/NRF1/TFAM Axis in Parkinson's Disease.
  • 1 Mar 2026
  • BioFactors (Oxford, England)
Elesclomol Promotes oxLDL-Mediated Foam Cell Formation and Cuproptosis in Macrophages.
  • 1 Mar 2026
  • BioFactors (Oxford, England)
ANXA5: A Multi-Omics-Derived, UPR-Associated Dual-Function Biomarker for Prognosis and Immunotherapy Response Prediction in Glioma.
  • 1 Mar 2026
  • BioFactors (Oxford, England)
Molecular Extremes of Ovarian Response: Divergent PI3K/AKT/mTOR Signaling and Oxidative Stress Patterns in Low and High Responders Undergoing InVitro Fertilization.
  • 1 Mar 2026
  • BioFactors (Oxford, England)
ISG15 Mediates Oxidative Stress Modulation in T2DM Patients by Directly Targeting PIK3R2.
  • 1 Mar 2026
  • BioFactors (Oxford, England)
Title not available
  • 1 Mar 2026
  • BioFactors
Phytoestrogenic Isoflavone Formononetin Attenuates Motor Deficits and Mitochondrial Impairment by Regulating SIRT1/PGC-1α/NRF1/TFAM Axis in Parkinson's Disease.
  • 1 Mar 2026
  • BioFactors (Oxford, England)
Elesclomol Promotes oxLDL-Mediated Foam Cell Formation and Cuproptosis in Macrophages.
  • 1 Mar 2026
  • BioFactors (Oxford, England)
ANXA5: A Multi-Omics-Derived, UPR-Associated Dual-Function Biomarker for Prognosis and Immunotherapy Response Prediction in Glioma.
  • 1 Mar 2026
  • BioFactors (Oxford, England)
Molecular Extremes of Ovarian Response: Divergent PI3K/AKT/mTOR Signaling and Oxidative Stress Patterns in Low and High Responders Undergoing InVitro Fertilization.
  • 1 Mar 2026
  • BioFactors (Oxford, England)

FAQs on BioFactors